Patrick Chen

Patrick Chen is a seasoned professional in the biopharmaceutical industry with extensive experience in CMC regulatory and manufacturing processes. Currently serving as Senior Vice President CMC Regulatory at Benitec Biopharma Inc. since May 2025, Patrick oversees CMC content in regulatory submissions and develops CMC strategies for drug development. Previous roles include Vice President CMC / Tech Ops at Senti Biosciences, where significant process improvements led to IND approval and the initiation of a Phase 1 clinical trial, and Vice President of Manufacturing at Grace Science, focusing on viral vector gene therapies. Patrick's background also includes leadership positions at Sangamo Therapeutics, Genentech, Chiron Corporation, Amgen, BASF Bioresearch Corp, and XOMA, complemented by an MBA from Babson College and a BS in Chemical Engineering from UCLA.